Lord Sharpe of Epsom debates involving the Department of Health and Social Care during the 2019 Parliament

Covid-19: Update

Lord Sharpe of Epsom Excerpts
Tuesday 20th April 2021

(3 years ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Sharpe of Epsom Portrait Lord Sharpe of Epsom (Con)
- Hansard - -

My Lords, one of the very few positives to come out of the pandemic is that the spotlight has shone on the superb life sciences sector in this country. For example, 47% of all global genomic sequencing is conducted in the UK. Could my noble friend the Minister elaborate on any future collaboration plans between the Government and the sector and how we intend to continue to grow our world-leading position in this space?

Lord Bethell Portrait Lord Bethell (Con)
- Hansard - - - Excerpts

My noble friend is entirely right: life sciences is a huge national strength. It was a quiet industry that people did not speak of much; now it is centre stage. Post Brexit, the role of the MHRA, as one of the world’s leading regulators, is something of which we can be enormously proud as a country. It is also making a lot of businesses think that the UK should very much be the focus of their investment, going forward. BEIS and the DHSC are working together very closely, through the Office for Life Sciences, to ensure that the message is heard loud and clear, around the world, that Britain is the right place to invest.

Health: Brain Tumours

Lord Sharpe of Epsom Excerpts
Tuesday 19th January 2021

(3 years, 3 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Bethell Portrait Lord Bethell (Con)
- Hansard - - - Excerpts

My Lords, £40 million was announced in May 2018 for brain tumour research. To date, £9.3 million has been committed and £5.5 million will be committed from April 2018 to 2023. At this stage, as the noble Lord, Lord Hunt, alluded to, the allocation of budget is not the issue. Making sure that the pipeline of applicable research is in place is our challenge. That is why we have worked well with interested parties to put together a plan for trying to ginger along the basic science necessary to get those research projects activated.

Lord Sharpe of Epsom Portrait Lord Sharpe of Epsom (Con)
- Hansard - -

My Lords, in 2019, my 22-year-old son, Charlie, was diagnosed with a germinoma, which is a rare form of brain tumour. He was referred for proton-beam therapy at the Christie Hospital in Manchester by the excellent Dr Jeremy Rees of the National Hospital in Queen Square. First, I thank the Government for spending the vast amount of money required to establish this capability in the UK, which, I am pleased to say, I think has been successful. Is the second facility at UCLH still on track to come on stream in 2021? Perhaps the Minister might reflect on the clinical expertise that has developed over the last year since the establishment of the facility at the Christie Hospital.

Lord Bethell Portrait Lord Bethell (Con)
- Hansard - - - Excerpts

My Lords, it is fantastic news that my noble friend’s son has benefited so well from our considerable investment in proton-beam therapy. I wish both him and his son good luck on behalf of all noble Lords. I am not aware of any current plans to open a PBT site in Birmingham, but I can reassure him that the UCLH site in London is due to open this year and we look forward to that very much indeed. It was hoping to open in 2020 but plans were impacted by the pandemic. As with any ground-breaking technology, clinical expertise in PBT will continue to increase as our hard-working frontline radiological staff treat more and more patients.